Submitted by Anonymous (not verified) on 25 April 2025 - 12:50
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised